The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)
Open accessAbstract
Screening of our internal compound collection for inhibitors of the transforming growth factor beta1 (TGF-beta1) type I receptor (ALK5) identified several hits. Optimization of the dihydropyrroloimidazole hit 2 by introduction of a 2-pyridine and 3,4-methylenedioxyphenyl group gave 7, a selective ALK5 inhibitor. With this information, optimization of the triarylimidazole hit 8 gave the selective inhibitor 14, which inhibits TGF-beta1-induced fibronectin mRNA formation while displaying no measurable cytotoxicity in the 48 h XTT assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Suzuki, A. (1999) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(98)01055-9 · Cited by 2,916
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,899
TGF-β: Regulation of extracellular matrix
Roberts, A. B., McCune, B. K., & Sporn, M. B. (1992) · Kidney International · doi:10.1038/ki.1992.81 · Cited by 493
Eyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310
Nakamura, T., Miller, D., Ruoslahti, E., & Border, W. A. (1992) · Kidney International · doi:10.1038/ki.1992.183 · Cited by 247
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase
Gallagher, T. F., Seibel, G. L., Kassis, S., Laydon, J. T., Blumenthal, M. J., Lee, J. C., Lee, D., Boehm, J. C., Fier-Thompson, S. M., Abt, J. W., et al. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(96)00212-x · Cited by 219
2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis
Gallagher, T. F., Fier-Thompson, S. M., Garigipati, R. S., Sorenson, M. E., Smietana, J. M., Lee, D. M., Bender, P. E., Lee, J. C., Laydon, J. T., Griswold, D. E., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00189-z · Cited by 133
Boehm, J. C., Smietana, J. M., Sorenson, M. E., Garigipati, R. S., Gallagher, T. F., Sheldrake, P. W., Bradbeer, J. N., Badger, A. M., Laydon, J. T., Lee, J. C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960415o · Cited by 123
Baghdassarian-Chalaye, D., Toru‐Delbauffe, D., Gavaret, J. M., & Pierre, M. (1993) · Glia · doi:10.1002/glia.440070302 · Cited by 93
Cited by
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Self-citationMechanisms of Immune Evasion by Tumors
Drake, C. G., Jaffee, E., & Pardoll, D. M. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90002-9 · Cited by 688
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Self-citationDevelopment of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Transforming growth factor-β in cancer and metastasis
Jakowlew, S. B. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9006-2 · Cited by 517
The transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Jinnin, M., Ihn, H., & Tamaki, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017483 · Cited by 445
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
“these advances allowed the pharmacological interference of key pathways with neutralizing antibodies against TGFβ or TGFβ receptor kinase inhibitors.(319,320) While preclinical studies in mouse models have shown great promise for TGFβ pharmacological agents, the role of TGFβ as a tumor suppressor and critical role in…”
BackgroundRoles of TGF-β family signaling in stem cell renewal and differentiation
Watabe, T., & Miyazono, K. (2009) · Cell Research · doi:10.1038/cr.2008.323 · Cited by 428
Nucleocytoplasmic Shuttling of Smads 2, 3, and 4 Permits Sensing of TGF-β Receptor Activity
Inman, G. J., Nicolás, F. J., & Hill, C. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00585-3 · Cited by 417
DaCosta Byfield, S., Major, C., Laping, N. J., & Roberts, A. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.744 · Cited by 414
Self-citationDownregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
Shan, H., Zhang, Y., Lu, Y., Zhang, Y., Pan, Z., Cai, B., Wang, N., Li, X., Feng, T., Hong, Y., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp130 · Cited by 349
Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors
Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J.-F., Lai, C. S., Deng, D. Y., Sachidanandan, C., Bloch, K. D., & Peterson, R. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.052 · Cited by 343
Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells
Maeda, S., Hayashi, M., Komiya, S., Imamura, T., & Miyazono, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600067 · Cited by 339
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., & Imamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00103.x · Cited by 339
Zhang, J., Zheng, Y., Lee, J., Hua, J., Li, S., Panchamukhi, A., Yue, J., Gou, X., Xia, Z., Zhu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21964-0 · Cited by 312
M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
Xiao, X., Gaffar, I., Guo, P., Wiersch, J., Fischbach, S., Peirish, L., Song, Z., El-Gohary, Y., Prasadan, K., Shiota, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321347111 · Cited by 312
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Neoplasia · doi:10.1593/neo.04640 · Cited by 288
Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis
Liu, X., Hu, H., & Yin, J. Q. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01192.x · Cited by 261
The specificities of small molecule inhibitors of the TGFß and BMP pathways
Vogt, J., Traynor, R., & Sapkota, G. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.019 · Cited by 256
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
Bellina, F., Cauteruccio, S., & Rossi, R. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.02.075 · Cited by 254
Franco-Barraza, J., Francescone, R., Luong, T., Shah, N., Madhani, R., Cukierman, G., Dulaimi, E., Devarajan, K., Egleston, B. L., Nicolas, E., et al. (2017) · eLife · doi:10.7554/elife.20600 · Cited by 112
Moratal, C., Raffort, J., Arrighi, N., Rekima, S., Schaub, S., Dechesne, C. A., Chinetti, G., & Dani, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35429-w · Cited by 101
Activin E controls energy homeostasis in both Brown and white adipose tissues as a hepatokine
Hashimoto, O., Funaba, M., Sekiyama, K., Doi, S., Shindo, D., Satoh, R., Itoi, H., Oiwa, H., Morita, M., Suzuki, C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.008 · Cited by 77
Waghabi, M. C., de Souza, E. M., de Oliveira, G. M., Keramidas, M., Feige, J.-J., Araújo-Jorge, T. C., & Bailly, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-09 · Cited by 66
Metadata
- Authors
- Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., Olson, B. A., Weinstock, J., & Laping, N. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-01-30
- Volume
- 45
- Issue
- 5
- Pages
- 999-1001
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1976123775
- Cited by
- 308
- References
- 12
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.